RA CAPITAL MANAGEMENT, L.P.
Q3 2022 13F-HR Holdings
Net value change ($000)
+936,992
(25.0%)
New positions
13
Sold out positions
20
Turnover %
14.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Forma Therapeutics Holdings, Inc. | 117,692 | 189.6% |
| RYTM | 113,826 | 563.1% |
| BIIB | 102,056 | 68.8% |
| LEGN | 95,415 | NEW |
| ASND | 77,950 | 11.1% |
| Third Harmonic Bio, Inc. | 65,934 | NEW |
| COGT | 59,881 | NEW |
| FULC | 56,630 | NEW |
| CTKB | 53,391 | 37.2% |
| ABOS | 52,078 | 113.4% |
Top Reduces (Value $000, Stocks/ETFs)
| VERU | -89,270 | -100.0% |
| POINT Biopharma Global Inc. | -61,311 | -100.0% |
| NTRA | -46,437 | -100.0% |
| DYN | -19,271 | -100.0% |
| GH | -19,217 | -100.0% |
| TNYA | -15,349 | -76.8% |
| Icosavax, Inc. | -15,327 | -44.9% |
| OTONOMY, INC. | -11,648 | -100.0% |
| VOR | -11,010 | -19.9% |
| LIANY | -9,985 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|